D-99 liposomal doxorubicin data

The Princeton, N.J., company presented data from the first 23 patients in a 41-patient Phase II open-label trial. Patients received 60 mg/m2 of D-99, and 500 mg/m2 each of cyclophosphamide and 5-FU ev...